文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

院前SIGARC评分评估感染性休克患者院内、30天和90天死亡率

The prehospital SIGARC score to assess septic shock in-hospital, 30-day and 90-day mortality.
PubMed 文献 · Am J Emerg Med · 2020-10-08
一句话结论院前SIGARC评分≥2与感染性休克患者30天和90天死亡率升高相关,可用于早期风险分层。

院内总死亡率为31%,30天和90天死亡率分别为28%和33%。该观察性结果需前瞻性研究证实。

要点

  • SIGARC评分由5项各1分组成:休克指数≥1、GCS<13、年龄>65岁、呼吸频率>22、合并症≥2项。
  • 研究人群为院前由移动ICU救治的感染性休克患者,院内总死亡率31%。
  • 该评分为观察性研究结果,需前瞻性研究证实后方可作为常规决策工具。

适用人群与场景

  • (本栏提炼含原文里核对不到的数值,已删除,请以原文为准)

诊断标准与关键阈值

  • SIGARC评分由5项各计1分组成:休克指数≥1、格拉斯哥昏迷评分(GCS)<13、年龄>65岁、呼吸频率>22、合并症定义为以下至少2种基础疾病:高血压、冠心病、慢性心力衰竭、慢性肾功能衰竭、慢性阻塞性肺疾病、糖尿病、肿瘤病史和人类免疫缺陷病毒感染。
  • 原文任意选择SIGARC评分≥2作为定义严重性的阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为回顾性研究,纳入406例院前由MICU救治的感染性休克患者,平均年龄71±15岁,男性268例(66%)。
  • 感染推测来源:肺部42%、消化道25%、泌尿道17%。
  • 院内总死亡率为31%,30天死亡率为28%,90天死亡率为33%。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究。
  • 局限:回顾性设计、单中心(原文未明确说明多中心)、观察性结果需前瞻性研究证实;原文未提及样本量计算、盲法等信息。

对床旁实践的改变

  • 对于院前由MICU救治的感染性休克患者,SIGARC评分≥2可提示30天和90天死亡风险升高,可能有助于早期风险分层和分诊决策。
  • 该评分为观察性研究结果,需前瞻性验证,不能作为常规决策的唯一依据。
  • 原文未提及该评分对急诊或ICU具体处置流程的改变。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: In the pre-hospital setting the early identification of septic shock (SS) patients presenting with a high risk of poor outcome remains a daily challenge. The development of a simple score to quickly identify these patients is essential to optimize triage towards the appropriate unit: emergency department (ED) or intensive care unit (ICU). We report the association between the new SIGARC score and in-hospital, 30 and 90-day mortality of SS patients cared for in the pre-hospital setting by a mobile ICU (MICU).

METHODS: SS patients cared for by a MICU between 2017, April 15th, and 2019, December 1st were included in this retrospective study. The SIGARC score consists of the addition of 5 following items (1 point for each one): shock index≥1, Glasgow coma scale<13, age > 65, respiratory rate > 22 and comorbidity defined by the presence of at least 2 underlying conditions among: hypertension, coronaropathy, chronic cardiac failure, chronic renal failure, chronic obstructive pulmonary disease, diabetes mellitus, history of cancer and human immunodeficiency virus infection. A threshold of SIGARC score ≥ 2 was arbitrarily chosen to define severity for its usefulness in clinical practice.

RESULTS: Data from 406 SS patients requiring MICU intervention in the pre-hospital setting were analysed. The mean age was 71 ± 15 years and 268 of the patients (66%) were male. The presumed origin of SS was pulmonary (42%), digestive (25%) or urinary (17%) infection. Overall in-hospital mortality was 31% with, 30 and 90-day mortality was respectively 28% and 33%. A prehospital SIGARC score ≥ 2 is associated with an increase in 30 and 90-day mortality with HR = 1.57 [1.02-2.42] and 1.82 [1.21-2.72], respectively.

CONCLUSION: A SIGARC score ≥ 2 is associated with an increase in in-hospital, 30 and 90-day mortality of SS patients cared for by a MICU in the prehospital setting. These observational results need to be confirmed by prospective studies.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jouffroy R, Gilbert B, Tourtier JP, et al. The prehospital SIGARC score to assess septic shock in-hospital, 30-day and 90-day mortality. Am J Emerg Med. 2020. PMID: 34348435. doi:10.1016/j.ajem.2020.10.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。